VKTX
Viking Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$34.51
+1.57%0
Insider buys (3m)
3
Insider sells (3m)
-$6.3M
Net value (3m)
+21.2%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 7, 2026 | Kelly-Gemmell Dorothy Elizabeth · director | A-Award | 6,333 | $0.00 |
| Aug 7, 2026 | Kelly-Gemmell Dorothy Elizabeth · director | A-Award | 40,800 | $32 |
| Jul 29, 2026 | ZANTE GREG · officer: Chief Financial Officer | Sale | 21,217 | $33 |
| Jul 29, 2026 | Lian Brian · director, officer: President & CEO | A-Award | 221,667 | $0.00 |
| Jul 29, 2026 | Mancini Marianna · officer: Chief Operating Officer | A-Award | 31,667 | $0.00 |
| Jul 29, 2026 | Lian Brian · director, officer: President & CEO | Sale | 148,517 | $33 |
| Jul 29, 2026 | Mancini Marianna · officer: Chief Operating Officer | Sale | 18,217 | $33 |
| Jul 29, 2026 | ZANTE GREG · officer: Chief Financial Officer | A-Award | 31,667 | $0.00 |
| Jun 3, 2026 | Chen Hubert C · officer: Chief Medical Officer | A-Award | 190,000 | $31 |
| Mar 10, 2026 | Aubuchon Neil William · officer: Chief Commercial Officer | Purchase | 4,475 | $34 |
| Jan 26, 2026 | Aubuchon Neil William · officer: Chief Commercial Officer | A-Award | 180,000 | $32 |
| Jan 5, 2026 | Rowland Charles A Jr · director | A-Award | 20,400 | $35 |
| Jan 5, 2026 | Mancini Marianna · officer: Chief Operating Officer | Sale | 1,600 | $35 |
| Jan 5, 2026 | ZANTE GREG · officer: Chief Financial Officer | A-Award | 91,000 | $35 |
| Jan 5, 2026 | ZANTE GREG · officer: Chief Financial Officer | A-Award | 41,000 | $0.00 |
| Jan 5, 2026 | Mancini Marianna · officer: Chief Operating Officer | A-Award | 91,000 | $35 |
| Jan 5, 2026 | MACARTNEY LAWSON · director | A-Award | 3,150 | $0.00 |
| Jan 5, 2026 | ZANTE GREG · officer: Chief Financial Officer | Sale | 1,500 | $32 |
| Jan 5, 2026 | Mancini Marianna · officer: Chief Operating Officer | A-Award | 41,000 | $0.00 |
| Jan 5, 2026 | Lian Brian · director, officer: President & CEO | A-Award | 176,300 | $35 |
| Jan 5, 2026 | Mancini Marianna · officer: Chief Operating Officer | Sale | 10,500 | $34 |
| Jan 5, 2026 | ZANTE GREG · officer: Chief Financial Officer | Sale | 31,961 | $32 |
| Jan 5, 2026 | Lian Brian · director, officer: President & CEO | Sale | 6,400 | $35 |
| Jan 5, 2026 | FOEHR MATTHEW W · director | A-Award | 3,150 | $0.00 |
| Jan 5, 2026 | MACARTNEY LAWSON · director | A-Award | 20,400 | $35 |
| Jan 5, 2026 | Rowland Charles A Jr · director | A-Award | 3,150 | $0.00 |
| Jan 5, 2026 | ZANTE GREG · officer: Chief Financial Officer | A-Award | 32,049 | $0.00 |
| Jan 5, 2026 | FOEHR MATTHEW W · director | M-Exempt | 16,000 | $3.33 |
| Jan 5, 2026 | Mancini Marianna · officer: Chief Operating Officer | A-Award | 32,049 | $0.00 |
| Jan 5, 2026 | FOEHR MATTHEW W · director | Sale | 16,000 | $35 |
Institutional positioning
13F filings over the trailing two quarters
New 140Increased 304Reduced 262Sold out 50
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BLACKROCK, INC. | Increased | 6,880,290 | May 13, 2026 |
| FMR LLC | Increased | 6,335,756 | Aug 13, 2026 |
| BlackRock, Inc. | Reduced | 6,189,649 | Aug 7, 2026 |
| FMR LLC | Reduced | 6,024,753 | May 15, 2026 |
| STATE STREET CORP | Increased | 5,606,394 | Aug 7, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 5,053,663 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 5,012,502 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 4,903,067 | Aug 14, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Reduced | 4,820,309 | May 15, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Increased | 4,484,263 | Aug 13, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 4,464,298 | May 8, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 4,432,142 | May 15, 2026 |
| STATE STREET CORP | Reduced | 4,395,557 | May 15, 2026 |
| TWO SIGMA INVESTMENTS, LP | Reduced | 3,937,414 | Aug 14, 2026 |
| MORGAN STANLEY | Increased | 3,486,040 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 7, 2026